News

Jul

CFFC Facebook Posts – July 2020 – Part 1

07/01/2020 - My Self Quarantine is Coming to an End – As we begin to experiment with rejoining the outside world, Gunnar Esiason remoinds us that common sense precautions are not hard to do. 07/02/2020 - Humor Is the Best Medicine for My CF – An interesting outlook on – and survival technique for – life with CF. 07/03/2020 - Biofilm ‘Channels’ May Offer Better Way of Treating CF Bacterial Infections – Once again, basic science uncovers details about bacterial structure that may produce new approaches to infections. 07/04/2020 - Brianna Collichio sings anthem at a NFL game- N.Y. Jets - A throw back, but what could be more appropriate for the 4th of July than to listen to Brianna belt out the National Anthem from her CF lungs. 07/05/2020 - CF Champions: Charlotte Giroux – CF champions exist all around the world. Here's one story from our Canadian neighbors. 07/06/2020 - What to Look for in a Relationship When You Have CF – Emotional issues in CF can be as challenging as the medical issues. This blogger shares her thoughts on the foundations for effective relationships. 07/07/2020 - NuvoAir Home Monitoring System Bolsters Telemed Use in CF, Survey Finds – While the pandemic has raised the general awareness of infection risk, the CF community has always been aware of the risks associated with clinic visits. This preliminary study indicates that critical data can be added to virtual clinic visits. 07/08/2020 - Multiple Input Opportunities Relating to COVID-19 – The CF Foundation is seeking observations on various aspects of the COVID-19 pandemic. 07/09/2020 - How Being Furloughed Taught Me to Slow Down – Some times it takes a dramatic event to get us to reexamine how we should manage our life. 07/10/2020 - Orkambi Benefits CF Patients Across Levels of Lung Health, Study Finds – Researchers in France expanded the range of patients using Orkambi beyond the lung function parameters used in the drugs clinical trials. They found benefits in addition ...

Jul

Multiple Input Opportunities Relating to COVID-19

The CF Foundation is seeking input from the CF community on three areas of evolving care relating to the COVID-19 pandemic plus interest in future projects. The announcement from Community Voice follows. The CF Foundation is recruiting for multiple projects to better understand the impacts of COVID-19 on the cystic fibrosis community. Please see below to learn about some of these opportunities and fill out the brief interest survey by Friday, July 17th to get involved. Document Review Opportunity: Risk Assessment Tool As the country reopens, the Foundation's Communications Team is looking to get feedback via email on a potential risk assessment tool that will be used to help guide discussions between people with CF and their care teams on which activities they can return to based on their own risk tolerance and circumstances. Feedback gathered will be used to help determine whether this tool would be useful and how it can be improved. Interview/Focus Group Opportunity: Risk Perception on Reopenings The Communications Team is also hosting a series of focus groups and interviews to understand the CF community's perceptions surrounding risk tolerance, priorities, and fears surrounding the country reopening. The insights gathered will help identify challenges the community faces, ideas on how to address them, and inform a future survey surrounding this topic. Interview Opportunity: Telehealth Services The Foundation's Policy Team is hosting interviews to learn about community members' experiences with telehealth during COVID-19, including from those who have not had telehealth experiences. The goal of these interviews is identify the benefits and barriers of telehealth for people with CF and their families and will help inform a future survey surrounding this topic. Future COVID-19 Related Opportunities There may be future opportunities to provide feedback on projects related to COVID-19. If you are interested in being contacted for these projects, please fill out the interest survey below. Take the Interest Survey If you have questions regarding these opportunities, please email communityvoice@cff.org. 

Jul

CFFC Facebook Posts – June 2020 – Part 2

06/16/2020 - Mucus breakthrough could help patients breathe easy - Basic science is the first step on the path to new treatments. 06/17/2020 - My Experience With Telehealth – This blogger's telehealth experience highlighted two characteristics that are always important: self-advocacy and awareness to what your body is telling you. 06/18/2020 - Second-hand Smoke Affects Metabolism in Infants and Children with CF, Study Finds – This study emphasizes the importance of keeping children with CF out of environments with cigarette smoke. 06/19/2020 - Mask Wearing: The Dumbest Binary Political Issue Out There – Science,m not politics, define the benefits that make masks worth the “inconvenience.” 06/20/2020 - Faces of a Clinical Trial – Jenna Coombs – Another entry in Cystic Fibrosis Canada's ongoing series of personal experiences with clinical trials. 06/21/2020 - CFRD is the Cloud in My Trikafta Silver Lining – Perfect solutions are hard to come by. 06/22/2020 - How I Regained My Independence During the Pandemic – Despite a lifetime being alert to possible infection, coming out of the height of the pandemic adds heightened awareness. 06/23/2020 - Living with CF: A Partner’s Perspective – This story from the partner of a person living with CF shows the progression of understanding and adaptation. 06/24/2020 - What I’ve Learned From 11 CF Care Centers in 21 Years – You can learn many things through comparisons. 06/25/2020 - Face masks critical in preventing spread of COVID-19 – Another study that proves what you already know; however, this information needs to get out to the broader population – and extended to other situations like flu season, medical offices, etc. 06/26/2020 - Survey Opportunity - CF Care During COVID-19 – A team at the University of Arizona has produced a survey to gather information on the impact that COVID-19 has had on CF medications and telehealth. 06/27/2020 - Finding Fate in the Fallout – A story of recovery ...

Jun

Survey Opportunity – CF Care During COVID-19

The "stay at home" rules implemented in response to the COVID-19 pandemic has led to a re-examination of the delivery of health care; particularly regarding CF. A team at the University of Arizona is gathering information on the impact these changes have had on the CF community. Although Cystic Fibrosis Foundation is not directly involved in this survey, the following announcement was distributed by Community Voice: Topic: Medication Access and Telehealth in CF care during COVID-19 Opportunity: 20-minute Survey From: A team of investigators from the University of Arizona Respond by: Friday, July 10, 2020 at 11:59 p.m., ET   A team from the University of Arizona is conducting a survey about medication access and telehealth in CF care during the COVID-19 pandemic. They want to hear from the CF community – adults with CF and all caregivers of persons with CF (including but not limited to, parents, spouses/partners, other family members). 18 or older are welcome to participate in this survey.   To learn more about this anonymous, 20-minute survey, please click the button below. This survey will close on Friday, July 10, 2020 at 11:59 p.m., ET. Upon completing the survey, participants will have the option to enter a raffle for an Amazon gift card.   Complete the Survey   Please note the Cystic Fibrosis Foundation is not involved in this project beyond its dissemination. For additional information or questions please contact the Principal Investigator, Hannah Phan, PharmD, at hphan@pharmacy.arizona.edu.     The survey project team provides the following background on the first page of the survey: You are being asked to voluntarily participate in this survey study being conducted by investigators at the University of Arizona. The purpose of the survey is to describe current practices and perspectives of adult persons with CF, caregivers of persons with CF (including parents, spouses/partners, family members, etc.), with regards to medications and telehealth services during the COVID-19 Pandemic. You must be 18 years or older to participate.  Your participation in this survey is voluntary.  The survey is anonymous and no information will be asked that can be used to identify you.  Your participation in this study will involve completing a questionnaire regarding your perspectives on medication education as well as a few demographic questions. You may choose not to answer some of ...

Jun

Clinical Trial Alerts – June 2020

Cystic Fibrosis Foundation released the following clinical trial alert in June 2020. June 16, 2020 OPTION 2: Study of AzurRX MS1819 in enteric capsules in adults with cystic fibrosis and exocrine pancreatic insufficiency › Status: Enrolling Description: This study will look at the safety and effectiveness of the drug MS1819 in enteric capsules as a pancreatic enzyme replacement therapy (PERT). Age: 18 Years and Older Mutation: No Mutation Requirement Fev1% Predicted: 30% or greater Number of Visits: 10 Length of Participation: 8 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04375878

Jun

CFFC Facebook Posts – June 2020 – Part 1

06/01/2020 - Common virus could speed up cystic fibrosis – Another interaction with a virus that does not bode well for those living with CF. 06/02/2020 - What I Did When My Date Told Me He Had CF – We have shared stories about explaining CF from the perspective of the person living with CF. This blog post presents the view from the other side of the relationship. 06/03/2020 – The CF Recipe Book – Looking for ways to make your CF diet more interesting? If you're into Instagram you can follow “thecfrecipebook” for menu ideas. 06/04/2020 - I Did a Coronavirus Antibody Test; It Left Me With More Questions than Answers – Gunnar Esiason documents his travel through the pandemic timeline and comments on his good fortune. 06/05/2020 - Microbe DNA Discovery May Lead to Noninvasive Test for CF Infections – Who doesn't like the idea of noninvasive tests, but is another blood test noninvasive? 06/06/2020 - Redefining What Family Means – This blogger reminds us that the entire support network so crucial in CF is “family.” 06/07/2020 - A newly discovered disease may lead to better treatment of cystic fibrosis – People living with CF generally don't need/want another disease; however, this research opens the possibility of an alternate approach to CF treatments. 06/08/2020 - NHS in England to help people with CF stay home and safe – What's happening in the rest of the world? In England, they are looking to conduct some clinic work at home. 06/10/2020 - As Society Reopens, It’s Hard Not to Feel Like We Are Being Left Behind – Extending his thoughts on risk tolerance, Gunnar Esiason shares his feelings about the delayed inclusion in the “reopening” for people with CF – or other high risk factors. 06/11/2020 - How I Combat CF Survivor’s Guilt – It's hard not to compare yourself to others. It is particularly hard when you are doing better than your friends. 06/12/2020 -

May

CFFC Facebook Posts – May 2020 – Part 2

05/16/2020 - The best material for homemade face masks may be a combination of two fabrics – This article presents research on the effectiveness of different mask materials. 05/17/2020 - "Achieving balance": Sean's story – It's no surprise that CF life across the Atlantic isn't much different. 05/18/2020 - Anti-inflammatory benefits of Orkambi and Symkevi in cystic fibrosis are uncovered – The benefits of CFTR modulators appear to extend beyond improvement in clearing out the lungs. Presumably this study will be extended to Trikafta in time. 05/19/2020 - Gene Therapy, KB407, Seen to Restore CFTR Protein in Cell Studies – A promising step toward gene therapy. 05/20/2020 - Questions to Ask Yourself When Considering College With CF – Although schools and colleges shut down prematurely, it is still appropriate to consider further education. 05/21/2020 - Embrace Friendly Debate: Is Cystic Fibrosis a Condition or a Disease? - Gunnar Esiason contributes to CF Awareness Month by making us aware of the various terms attached to cystic fibrosis and offering his opinion on the best way to apply those terms. 05/22/2020 – CFFC Face Mask Offer – With a relaxing of our state's Pause in the Finger Lakes region (on the brink of the Memorial Day weekend), the urge to break cabin fever is strong. If (when?) you do, please stay safe; particularly, wear a face mask. CFFC still has an inventory of cloth face masks available to households that include someone living with CF. 05/24/2020 - How Trefoil Proteins Act to Thicken Mucus Detailed in Study – While this study adds to the complexity of conditions associated with CF, it also provides a new avenue for improving lung clearance. 05/25/2020 - How CF Steered Me Toward a Career in Music – Although the punchline to this blog [spoiler alert] is the new lease on life with Trikafta, it is also a story of finding new dreams when your original dream is out of reach. 05/26/2020 - Growing Lung Bacteria in Labs May ...

May

Opportunities to Provide Input

Cystic Fibrosis Foundation is seeking input on two aspects of life with CF: liver disease and CF related diabetes. The text of the announcements, including links to the related surveys, are presented below. CF Liver Disease Clinical Care Guidelines the CF Foundation will be developing CF Liver Disease Guidelines for individuals with cystic fibrosis. If you have experience with liver, biliary, or gallbladder issues, there are two opportunities to contribute to the development of these new guidelines. 1. Inform the Scope of GuidelinesTo help shape these guidelines, we kindly request that you complete the anonymous, 10-minute survey. The survey asks about your experience with and practice patterns around liver, biliary, and gallbladder disease; you may choose not to answer any or all questions. The survey will be distributed to members of the CF care team, individuals with CF and their family members, and hepatologists. The survey will close on Tuesday, June 2nd, 2020. TAKE SURVEY 2. Apply to join the CF Liver Disease Guidelines CommitteeWe are looking for multiple community members who have CF liver, biliary, or gallbladder experience to join the Guidelines Committee. This committee will review current literature to develop recommendation statements for liver, biliary, and gallbladder care in individuals with CF.Click here to learn more about the expectations and goals of this group. To apply for a position on the CF Liver Disease Guidelines Committee, please click on the button below. This questionnaire will close on Tuesday, June 2nd, 2020. Leaders of the committee will review completed applications and select finalists based on the information provided. APPLY FOR COMMITTEE CF-Related Diabetes CF-related diabetes (CFRD) affects over 35% of adults with CF and is consistently ranked as a high-priority for research by the CF community. 1. Inform the discussion   Following the series of focus groups held with many Community Voice members, the research team is now conducting a survey in partnership with the CF Foundation to learn more about the community’s: Priorities for future endocrine research Needs regarding CFRD-related education Perspectives on CFRD devices and technologies To take the 15-minute anonymous survey, please click the button below by Thursday, June 4th at ...

May

CFFC Facebook Posts – May 2020 – Part 1

05/01/2020 - Types of CFTR Mutations – May is CF Awareness Month. So, we are going to share links to basic information. This information will not necessarily new to you, but it may information you want to share with acquaintances to bring them up to speed on life with CF. 05/02/2020 – Treatments and Therapies – Continuing the CF Awareness month theme, here is a handy one page summary of CF treatments and therapies prepared by CF Ireland. 05/03/2020 - CF-Related Diabetes – CF Awareness Month. When you mention CF, thoughts go to lungs and digestion. CF related diabetes is also common within the community. 05/04/2020 – Lung Transplantation - CF Awareness Month. With advances in techniques and medications, transplantation has become a more option for those with advanced lung disease. 05/05/2020 - The Sweat Test – CF Awareness Month. While all newborns are screened for CF, the sweat test is still the definitive means for diagnosing CF. This pamphlet from CF Ireland provides an outline of the sweat test. 05/06/2020 - The Counseling Connection – CF Awareness Month. Mental health is an aspect of CF that may not get adequate recognition. This view of the importance of mental health care is provided by a practitioner with CF who also seeks therapy. 05/07/2020 - Being Transgender and Non-Binary in a CF World – CF Awareness Month (in a unique way). The primary themes of this blog are self-avocacy and care team building; however, the more subtle message is that CF is a non-discriminating disease. 05/08/2020 - COVID-19 Data Dump Delivers Good News for Cystic Fibrosis Population – CF Awareness Month – Gunnar Esiason points out news that is unsuspectingly positive for the CF population. 05/09/2020 - Research blast on... inflammation – CF Awareness Month – This “fun” report from UK's Cystic Fibrosis Trust explains the balance necessary in managing inflammation. 05/10/2020 - Recommendations Issued About Managing Chronic Disease in Children – CF Awareness Month – Perhaps awareness can go in many ...

May

Clinical Trial Alerts – May 2020

The following clinical trial alerts were issued by Cystic Fibrosis Foundation in May 2020. May 4, 2020 A study to evaluate tezacaftor/ivacaftor in adults with cystic fibrosis and two copies of the F508del mutation Status: Completed with results Description: This study evaluated the safety, effectiveness, and tolerability of the drug tezacaftor/ivacaftor (Symdeko®). This study was for people with CF ages 12 and older with two copies of the F508del CFTR mutation who had been taken off lumacaftor/ivacaftor (Orkambi®) due to respiratory side effects. Age: 12 Years and Older Mutation: Two Copies F508del Fev1% Predicted: 25 to 90% Number of Visits: 5 Length of Participation: 84 days ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT03150719 AeroVanc for the treatment of MRSA in people with CF Status: Completed with results Description: This study evaluated the safety and effectiveness of AeroVanc in treating persistent MRSA lung infections in people with cystic fibrosis. Age: 12 Years and Older Mutation: No Mutation Requirement Fev1% Predicted: 30 to 100% Number of Visits: 9 Length of Participation: 16 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT01746095 May 13, 2020 SIMPLIFY: Study to evaluate stopping inhaled hypertonic saline or dornase alfa in people with CF who are taking the triple-combination modulator, elexacaftor/tezacaftor/ivacaftor Status: Enroling Description: This study will test the effects and safety of stopping inhaled hypertonic saline or dornase alfa (Pulmozyme®) in teens and adults with CF who are also taking the triple-combination modulator, elexacaftor/tezacaftor/ivacaftor (Trikafta®). Trikafta® is intended to help CFTR function closer to normal, resulting in better clearance of mucus from the lungs. Inhaled hypertonic saline and dornase alfa are intended to thin airway surface liquid and improve clearance of mucus from the lungs. They are considered to be relatively burdensome therapies, so this study will look at the impact of stopping them in people who are also taking Trikafta®. Age: ...